Summit Street Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$1.39M |
| 2 |
Humana
HUM
|
+$355K |
| 3 |
Buckle
BKE
|
+$348K |
| 4 |
Elevance Health
ELV
|
+$239K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HF Sinclair
DINO
|
+$1.93M |
| 2 |
Gilead Sciences
GILD
|
+$1.88M |
| 3 |
MTOR
MERITOR, Inc.
MTOR
|
+$1.77M |
| 4 |
InterDigital
IDCC
|
+$1.3M |
| 5 |
Centene
CNC
|
+$1.24M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.2% |
| 2 | Materials | 16.41% |
| 3 | Healthcare | 15.61% |
| 4 | Financials | 15.08% |
| 5 | Consumer Discretionary | 11.75% |
Similar funds
Summit Street Capital Management's Q4 2020 Portfolio in Review
As of Q4 2020, Summit Street Capital Management held 36 positions worth $134M, up 18% from $113M the previous quarter. Its ten largest holdings account for 52% of the portfolio.
Summit Street Capital Management withdrew a net $9.37M in Q4 2020, closing 2 positions and reducing 8 holdings. Its most notable exit was Gilead Sciences, an estimated $1.88M position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Materials and Healthcare.
Against the trend, Summit Street Capital Management added an estimated $1.39M to Intel.
- Summit Street Capital Management added most to Intel in Q4 2020, an estimated $1.39M increase.
- Summit Street Capital Management's biggest Q4 2020 reduction was HF Sinclair, cutting an estimated $1.93M.
- Summit Street Capital Management fully exited Gilead Sciences in Q4 2020, selling an estimated $1.88M.
- Summit Street Capital Management's ten largest holdings make up 52% of its $134M portfolio in Q4 2020.
- Summit Street Capital Management opened 0 new positions and closed 2 in Q4 2020.
- Summit Street Capital Management's portfolio value rose 18% quarter-over-quarter to $134M.
Based on Summit Street Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.